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Abstract
The Wnt/b-catenin pathway controls cell proliferation, death and differentiation. Several families of extracellular proteins
can antagonize Wnt/b-catenin signaling, including the decoy receptors known as secreted frizzled related proteins (SFRPs),
which have a cysteine-rich domain (CRD) structurally similar to the extracellular Wnt-binding domain of the frizzled
receptors. SFRPs inhibit Wnt signaling by sequestering Wnts through the CRD or by forming inactive complexes with the
frizzled receptors. Other endogenous molecules carrying frizzled CRDs inhibit Wnt signaling, such as V3Nter, which is
proteolytically derived from the cell surface component collagen XVIII and contains a biologically active frizzled domain
(FZC18) inhibiting in vivo cell proliferation and tumor growth in mice. We recently showed that FZC18 expressing cells
deliver short-range signals to neighboring cells, decreasing their proliferation in vitro and in vivo through the Wnt/b-catenin
signaling pathway. Here, using low concentrations of soluble FZC18 and Wnt3a, we show that they physically interact in a
cell-free system. In addition, soluble FZC18 binds the frizzled 1 and 8 receptors’ CRDs, reducing cell sensitivity to Wnt3a.
Conversely, inhibition of Wnt/b-catenin signaling was partially rescued by the expression of full-length frizzled 1 and 8
receptors, but enhanced by the expression of a chimeric cell-membrane-tethered frizzled 8 CRD. Moreover, soluble, partially
purified recombinant FZC18_CRD inhibited Wnt3a-induced b-catenin activation. Taken together, the data indicate that
collagen XVIII-derived frizzled CRD shifts Wnt sensitivity of normal cells to a lower pitch and controls their growth.
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Introduction
The Wnt/b-catenin pathway controls cell fate through
regulation of cell proliferation and death, migration, differentia-
tion and metabolism [1]. Pathway activation involves interaction
of Wnt ligands with cell surface Frizzled receptors and LRP5/6
co-receptors. This disrupts the Adenomatous polyposis coli (APC)-axin
complex, thus halting proteasomal degradation of b-catenin,
which is stabilized and interacts with T-cell factor (TCF)
transcription factors, displacing repressors and recruiting activa-
tors of target gene expression.
The bioavailability of Wnts at the cell surface is regulated by
several families of extracellular proteins. Heparan sulfate glycos-
aminoglycans control Wnt diffusion, thus enhancing interaction of
Wnt ligands with Frizzled receptors [2]. Antagonists include
members of the Dickkopf (DKK) family that block canonical
signaling by binding to LRP5/6, thereby disrupting the Wnt-
induced Frizzled-LRP5/6 complex [3]. Wnt inhibitory factor-1
(WIF-1) binds directly to Wnts, altering their ability to interact
with the receptors. The extracellular decoy receptors known as
secreted frizzled-related proteins (SFRPs) have a frizzled cysteine-rich
domain (CRD) structurally similar to the extracellular Wnt-binding
domain of the frizzled receptors. Frizzled CRDs contain 10
cysteines at conserved positions, which form a highly conserved
3D structure, bind Wnts and form homodimers or heterodimers
[4]. Thus, SFRPs can modulate Wnt signaling by sequestering
Wnts through the CRD or by acting as dominant-negative
inhibitors, forming inactive complexes with the frizzled receptors
[5]. In addition, engineered SFRP-like proteins such as the soluble
CRD of the receptor Frizzled 8 bind Wnt3a and inhibit autocrine
Wnt signaling and tumor growth in mice carrying teratomas [6].
In addition to SFRPs, other endogenous molecules carrying
frizzled CRDs inhibit Wnt signaling. Among them, V3Nter is a
cell surface polypeptide that inhibits tumor growth and switches off
the b-catenin target gene expression signature in vivo [7,8]. V3Nter
is proteolytically derived from the cell surface extracellular matrix
component collagen XVIII [7,9,10] and contains a biologically
active frizzled domain (FZC18) (Figure 1A) [7]. The CRD in the
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FZC18 domain is highly conserved in frog, mouse and man, all 10
cysteines and the number and type of intervening amino-acids
being fully conserved [9]. Indeed, we previously showed a 100%
probability that the predicted 3D model of FZC18_CRD matches
the 3D structure of mouse SFRP3 and FZD8 CRDs [7]. In human
liver cancer, endogenous collagen XVIII is proteolyzed, releasing
the FZC18 precursor V3Nter. We have shown that low FZC18
protein expression in liver cancer correlated with markers of high
Wnt/b-catenin activity and vice versa [7].
In this work, we show that low concentration soluble FZC18
interacts with Wnt3a and with the receptors FZD1 and FZD8 in a
cell-free system. Consequently, FZC18 reduces cell sensitivity to
Wnt3a and inhibits Wnt/b-catenin signaling. In line with these
findings, FZC18 inhibitory effects were partially rescued by the
expression of FZD1 and FZD8 receptors, but enhanced by
expression of FZD8_CRD-GPI, a cell-membrane-tethered chime-
ric FZD8_CRD. Finally, we produced high-yield soluble recom-
binant human FZC18_CRD-Fc fusion protein, which inhibited
Wnt3a-induced b-catenin activation in vitro.
Materials and Methods
cDNA Clones
Human Igk-FZC18-myc/pSecTag2 (carrying an Igk signal
peptide) and mouse Wnt3a-V5/pCDNA3.1 mammalian expres-
sion vectors, Super8NTopflash and Super8NFopflash CRT report-
ers, Cyclin D1 promoter reporter D1D-944pXP2 and the
normalization Renilla luciferase vector pGL4.70[hRluc] were
previously described [7]. The episomal expression vector pCEP-
PU was from T. Sasaki [11]. Igk-FZC18-myc was transferred from
pSecTag2 to pCEP-PU by PCR synthesis of an 875-bp fragment
carrying 59-NheI and 39-BamHI restriction sites in the forward
and reverse primers, respectively. The PCR fragment was ligated
into pCRII-Topo-TA (Invitrogen), excised and subcloned into
pCEP-PU. Mouse FZD8_CRD-myc/pcDNA3, mFZD8_CRD-
Fc/pRK5 [12] (Addgene plasmid 16689) and empty pRK5
plasmid were from X. He, mFZD8_CRD-myc-GPI was from J.
Nathans [13], mFZD8-myc receptor/pEF1A [14] was from R.
Nusse, pEF1/myc-his was from Invitrogen and rat FZD1-myc
(Addgene plasmid 16798) was from R. Moon. Human
FZC18_CRD was PCR cloned into BamHI and KpnI in pIDZ-
Fc in frame with an Igk signal sequence and a C-terminal human
IgG Fc tag for affinity purification. A thrombin cleavage site was
included to allow removal of the Fc tag. The sequences of primers
were: forward, 59-GGG GGA TCC GCC CTG CTC GGG GCT
GAC-39; reverse #1, 59-GGG CTC GAG AGA TCC ACG CGG
TAC CAG TGC AGC CGG CCC AAT GAG-39; reverse #2, 59-
GGG CTC GAG TGC AGC CGG CCC AAT GAG-39.
Constructs were stably transfected in DHFR-deficient CHO cells
with Effectene transfection reagent (Qiagen), and clones selected in
media containing G418 (500 mg/ml, Sigma) and lacking hypo-
xanthine and thymidine. All cDNAs were checked by automatic
sequencing (Sequencing Facility, Rennes University Hospital,
France).
Biological Activity of Soluble FZC18
Collection of conditioned media (CM) from parental L cells
(control CM) and Wnt3a CM was performed as recommended by
ATCC and by R. Nusse lab website. For other CM, HEK293
EBNA cells were seeded at 2.26106 cells/10 mm dishes and
transfected with either FZC18-myc/pCEP-PU, mFZD8_CRD-
myc/pcDNA3, mFZD8_CRD-Fc/pRK5 or with the respective
empty vectors and, 24 hr later, fresh media were replaced by
DMEM (4.5 g/l glucose) without phenol red or FCS (Invitrogen).
Conditioned media were collected 48 hr later, centrifuged at 450 g
and filtered (0.2 mm). To obtain recombinant FZC18_CRD,
conditioned media from hFZC18_CRD-Fc clones were screened
for protein expression by ELISA and positive clones were
confirmed by Western blot analysis using anti-human IgG-Fc
antibody. The positive clones were further adapted to CD
OptiCHO medium supplemented with 8 mM L-Glutamine.
hFZC18_CRD-Fc producing cells were seeded into spinner flasks
at 26105 cells/ml and incubated at 37uC and 5% CO2 with
Figure 1. Stable expression of FZC18 in HEK293T cells. (A)
Schematic structure showing the variant 3 of collagen XVIII containing
DUF-959, FZC18, Tsp-1 (thrombospondin-1) and ES (endostatin)
domains and the FZC18 expression vector. Interrupted collagenous
indicates multiple triple helices (collagenous sequences) interrupted by
globular domains. Thick horizontal lines indicate the antibodies used.
SP, signal peptide; CRD, Cysteine-Rich Domain; myc, myc epitope tag.
(B) HEK293T cells stably expressing FZC18 (batches 1; 4; 5) or empty
vector (V) were fixed, permeabilized and immunostained with anti-myc,
followed by peroxidase-conjugated antibodies (brown). Cells were
counterstained with hematoxylin (blue). Original magnification: 6100.
Images were acquired on an Olympus BX60 microscope. (C) Immuno-
blot with anti-FZC18 (red) and anti-myc (yellow) antibodies in HEK293T
cell batches (1; 4; 5) stably expressing FZC18 or empty vector (V). a-
tubulin is a loading standard.
doi:10.1371/journal.pone.0030601.g001
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agitation at 80 rpm in humidified air for 10 days. The medium
was collected, cleared by centrifugation, filtered (0.45 mm) and
stored at 4uC until purification. The samples were loaded on a
protein A column following equilibration with 20 mM sodium
phosphate, 20 mM sodium citrate, pH 7.5. The column was
washed with the same buffer until effluent absorbance returned to
baseline. The bound proteins were eluted with 20 mM sodium
phosphate, 100 mM sodium citrate, pH 2.5 followed by rapid
neutralization by adding 0.1 volume of 1 M Tris-hydrochloride,
pH 9.0. The yield of the purified proteins was approximately
1,5 mg/l and purity was over 40%, as estimated by sandwich
ELISA using anti-Fc antibody (Abcam AB1927) for capture and
peroxidase-conjugated secondary antibody (Sigma A0170) for
detection. Purified proteins were stored at 280uC until use.
Immunological Methods
Coimmunoprecipitations were done by incubating either
FZC18-myc or FZD8_CRD-myc pre-cleared CM with recombi-
nant mWnt3a (100 ng/ml; 2.7 nM) and either mouse anti-myc or
mouse IgG1 (Dako) on a rotary wheel at 4uC overnight. Then,
protein G magnetic beads (New England Biolabs), saturated
overnight in protein extracts from 293EBNA cells in RIPA buffer
(TrisHCl 50 mM, pH 7.4; 1% Triton-X-100; 25 mM Hepes;
150 mM NaCl; 0.2% Sodium deoxycholate, 5 mM MgCl2), were
added to immunocomplexes and incubated at 4uC, for 3 hr. After
washing in RIPA buffer, complexes were eluted in denaturing
sample buffer, resolved by 10% PAGE-SDS and immunoblotted.
For reverse coimmunoprecipitation experiments, either rabbit
anti-mWnt3a (C64F2, Cell Signaling) or rabbit IgG (Dako) was
incubated either with recombinant mWnt3a plus FZC18-myc CM
or with recombinant mWnt3a plus FZD8_CRD-myc CM.
Coimmunoprecipitation of FZC18-myc with either recombinant
mFZD1_CRD-Fc (100 ng/ml) or mFZD8_CRD-Fc CM was
done as described above, using protein G magnetic beads binding
the Fc tags. Immunoblots were performed with mouse anti-myc
(Invitrogen) and with monoclonal rat anti-FZD1_CRD or anti-
FZD8_CRD antibodies (R&D). Signal from immunoblots was
detected by enhanced chemiluminiscence, as described [7].
Results
The frizzled domain of collagen XVIII inhibits cell
proliferation and DNA synthesis
We produced zeocin-resistant mass cultures of 293T cells stably
expressing FZC18 or empty vector. To avoid clonal variability, we
expanded colonies showing different densities of FZC18 (+) cells
(Figure 1B). As FZC18 locates preferentially at the cell surface [7],
cell permeabilization followed by immunocytochemistry allowed
identification of all cells expressing the protein of interest, regardless
of protein maturation. Thus, batch #1 showed a lower density of
FZC18 (+) cells (Figure 1B) and lower FZC18 expression by
immunoblot than batch #4 and #5 cells (Figure 1C). When
passaged routinely, FZC18 (+) cells grew more slowly, formed
smaller cell plates than vector cells and secreted soluble FZC18
(Figure S1, B and C). Simultaneous detection of N- and C-terminal
epitopes in this fusion protein indicated preservation of FZC18
integrity in cells (Figure 1C) and in the medium (Figure S1C). An 8-
day time course cell proliferation assay showed that FZC18-
expressing cells grew more slowly than vector cells (Figure 2A).
3HThymidine incorporation rates into DNA showed that FZC18
reduces cell proliferation and DNA synthesis (Figure 2B). Through-
out the 8-day cell proliferation assay, mitochondrial succinate
dehydrogenase activity in living cells (MTT assay) confirmed the
decrease in cell growth in FZC18-expressing cells (Figure S2). The
decrease in proliferation rates was correlated with the expression
levels of FZC18 in the stable cell cultures (Figure 1B). No significant
difference in spontaneous cell death was observed in these cells
compared to vector-expressing cells by flow cytometry search for
subG1, hypo-diploid cells (not shown).
FZC18 reduces cell sensitivity to soluble Wnt3a
Incubation of vector and FZC18-expressing 293T cells with
conditioned medium (CM) from L cells secreting soluble Wnt3a
(Wnt3a CM) confirmed that FZC18 reduces Wnt3a-induced Wnt
signaling (Figure 3), b-catenin stabilization, cyclin D1 promoter
activity and protein expression (Figure S3). FZC18-expressing cells
showed lower amounts of steady-state b-catenin protein (Figure
S3A) and cyclin D1 promoter activity than control cells (Figure
S3B). In particular, cyclin D1 protein expression in response to
soluble Wnt3a was considerably stronger in vector cells than in
FZC18 cells (Figure S3C), indicating that FZC18 abrogates the
response to Wnt3a. The dose-response curve to different dilutions
of Wnt3a CM showed that FZC18-expressing cells could
efficiently build up a CRT response to Wnt3a, in such a way
that the higher the concentration of Wnt3a CM, the higher the
fold-change in CRT. However, the absolute CRT levels in
FZC18-expressing cells were 5 to 8 folds lower than those in vector
cells (Figure S3D).
Figure 2. FZC18 inhibits cell proliferation and DNA synthesis.
(A) HEK293T cells stably expressing FZC18 (batches 1; 4; 5) or empty
vector (vector) were seeded at low density and cell number was
determined on an 8-day time course by cell counting. (B) Cells were
serum-starved for 48 hr and stimulated with 10% FBS twice, as shown
(arrows). At each time point, cells were pulsed with 1 mCi/ml 3H
thymidine for 2 hr before lysis. Incorporated radioactivity is expressed
as cpm/mg protein.
doi:10.1371/journal.pone.0030601.g002
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Despite lower pre-Wnt3a and post-Wnt3a b-catenin stabiliza-
tion and downstream signaling events in FZC18 cells (Figures 3
and S3), a given strength of Wnt3a stimulus induced the same fold-
change in CRT both in vector and FZC18 cells (Figure S4).
Likewise, it has been recently shown that in a normal cell context,
different cell systems respond to Wnt stimulation with similar fold-
change despite their different starting and output levels in Wnt/b-
catenin signaling [15]. Thus, FZC18 may not impair downstream
processing of Wnt stimuli, but it seems to decrease cell sensitivity to
Wnt3a, probably by blocking Wnt access to frizzled receptors.
Soluble FZC18 binds Wnt3a
Co-expression of FZC18 and Wnt3a in non permeabilized
AT3F1S315 mouse hepatoma cells [16] followed by confocal
microscopy analysis revealed that both proteins colocalized at the
cell surface, highlighting cell contacts (Figure 4A). We further
confirmed that HEK293T cell clones stably expressed FZC18 at
the cell surface by immunostaining with antibodies detecting the
N- and C-termini of the FZC18-myc fusion protein (Figure S5A).
Moreover, subcellular fractionation confirmed that FZC18 was
exclusively detected in the crude membrane fraction (Figure S5B),
indicating that the protein is indeed addressed to the secretory
pathway.
Using protein extracts from cells cotransfected with both FZC18
and Wnt3a, we previously showed that these ectopically expressed
molecules interact [7]. However, cysteine-rich proteins like Wnts
and the Frizzled CRDs may get clogged within the secretory
pathway [2], leading to high intracellular concentration and
spurious interactions. Here, we wished to study these interactions
in a cell-free system, using soluble FZC18 and Wnt3a, at low
concentrations. Despite easy detection of FZC18-myc by immu-
nocytochemistry, immunoblot detection showed no signal in non-
concentrated CM, in contrast to FZD8_CRD-myc, which was
detected at high levels (Figure S5C). Concentration of FZC18 CM
by 13 folds was required to observe a detectable signal by
immunoblot (Figure S5C). For coimmunoprecipitation, we added
purified recombinant Wnt3a to non-concentrated FZC18-myc or
FZD8_CRD-myc CM. Wnt3a concentration (2.7 nM) was within
the physiological range [13,17,18,19,20]. Under these conditions,
both FZC18-myc and FZD8_CRD-myc pulled down Wnt3a
(Figure 4B). Accordingly, reverse co-immunoprecipitation revealed
that Wnt3a pulled down both FZC18-myc and FZD8_CRD-myc
(Figure S5D). Additionally, both precipitation and immunoblot
with anti-myc antibody confirmed the presence of soluble FZC18
and FZD8_CRD at the expected amounts in these CM (Figure
S5E).
Extracellular FZC18 inhibits Wnt3a-induced Wnt/b-
catenin signaling
We tested whether the CRD of FZC18 (FZC18_CRD) could
effectively inhibit Wnt signaling. FZC18_CRD was cloned in
frame with a human Igk signal sequence and a human Fc tag from
IgG. Human FZC18_CRD-Fc preparations with 40% purity were
tested for biological activity. As expected, hFZC18_CRD-Fc dose-
dependently inhibited Wnt3a-induced CRT (Figure 5). Inclusion
of a thrombin cleavage site did not significantly affect Wnt
inhibitory activity of hFZC18_CRD-Fc (Figure S6). Taken
together, these findings support the concept that FZC18 exerts
its biological effects in the extracellular compartment and that the
CRD of FZC18 has Wnt inhibitory activity.
FZC18 seems to provide short-range signals, thus working as an
SFRP-like molecule [8]. We thus confirmed whether FZC18-
expressing cells impact on the microenvironment of adjacent cells
and modulate their response to Wnt stimuli. FZC18-expressing
Figure 3. FZC18 reduces cell sensitivity to soluble Wnt3a.
HEK293T cell batches stably expressing FZC18 (1; 4; 5) or empty vector
(V) were incubated with either 50% control or Wnt3a conditioned
medium (CM) for 16 hr before lysis. CRT (b-catenin-T-Cell factor
Regulated Transcription) assays using Super8NTopflash or the negative
control Super8NFopflash reporters are representative of three indepen-
dent experiments performed in triplicate and normalized to Renilla
luciferase activity (mean6SD).
doi:10.1371/journal.pone.0030601.g003 Figure 4. Soluble FZC18 binds Wnt3a. (A) FZC18 colocalizes with
Wnt3a at the cell surface (arrows). AT3F1S315 hepatoma cells were co-
transfected with FZC18 and Wnt3a vectors. FZC18 (green) was detected
by anti-myc+FITC-labeled IgG. Wnt3a (red) was detected by anti-
Wnt3a+biotinylated IgG+streptavidine-Texas red. Cells were not per-
meabilized. Nuclei were labelled blue with DAPI. Images were acquired
using a Leica TCS NT system on a Leica DMB confocal microscope at
original magnification 6630. (B) Soluble FZC18 binds Wnt3a. Condi-
tioned medium from HEK293-EBNA cells transiently expressing FZC18
was incubated with recombinant Wnt3a overnight at +4uC. FZC18 was
immunoprecipitated with anti-myc and immunoblotted with anti-
Wnt3a. Conditioned medium from HEK293-EBNA cells transiently
expressing FZD8_CRD-myc was used as a positive control of
coimmunoprecipitation. Ig, immunoglobulins. Asterisks denote inputs.
For 106, FZC18-myc CM was incubated with Wnt3a and then
concentrated 10 folds by TCA precipitation.
doi:10.1371/journal.pone.0030601.g004
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cells were co-cultured with parental 293 cells expressing the CRT
reporter. Co-cultures were established at different ratios of FZC18
(+) cells to a constant number of reporter cells in the presence of
50% Wnt3a CM (Figure S7). Under these conditions, the response
of the reporter cells to soluble Wnt3a was inversely proportional to
the number of FZC18 (+) cells in the co-culture system.
Frizzled 1 and 8 receptors partially rescue the inhibition
of Wnt3a-induced b-catenin signaling by FZC18
We tested whether increasing the availability of cell surface
frizzled receptors in FZC18-expressing cells could compete with
FZC18, thereby enhancing Wnt signaling. To this end, FZC18-
expressing and vector cells were transfected with increasing
amounts of full-length FZD1 or FZD8 receptor cDNAs and
incubated in the presence of Wnt3a CM (Figure 6, A and B).
FZD1 and FZD8 receptor expression led to up-regulation of CRT
in both vector and FZC18-expressing cells. Vector and FZC18
cells expressing FZD1 exhibited similar CRT (Figure 6A). By
contrast, 100 ng of FZD8 cDNA was required to reach 50% of
vector cells’ maximal CRT in FZC18-expressing cells, whereas
vector cells’ maximal activity was obtained with 5 ng of FZD8
cDNA. Interestingly, although lower amounts of FZD1 (0.5 and
0.75 ng) or FZD8 (0.5 to 10 ng) cDNAs activated CRT in a dose-
dependent manner, higher amounts of FZD1 (1 to 250 ng) or
FZD8 (50 to 250 ng) cDNAs gradually reduced CRT (Figure 6, A
and B). Although high doses of FZ receptor cDNA appeared non-
specifically inhibitory (Figures 6 and S8), mouse FZD1 and
Drosophila FZ3 may behave as antagonists of canonical Wnt/b-
catenin signaling [21,22]. Excessive ectopic stimulation of b-
catenin signaling via frizzled receptors may result in saturation of
the signal transduction capacity of pathway components down-
stream to the frizzled receptors. In keeping with this hypothesis,
mouse wild-type FZD1 inhibits Wnt signaling less efficiently than
does C-terminally deleted mouse FZD1 [21]. These data led us to
test a hypothetical synergy between FZC18 and FZ CRDs,
capable of binding Wnts but unable to transduce downstream
signal.
Using FZC18-expressing cells, we compared the effects of the
full-length FZD8 receptor, FZD8_CRD and a FZD8_CRD
carrying a C-terminal glycosylphosphatidylinositol (GPI) anchor
attaching the CRD at the cell surface (FZD8_CRD-GPI). Within
the 10 pg-100 ng range of transfected cDNA, FZD8_CRD-GPI
and FZD8_CRD further reduced Wnt signaling in FZC18-
expressing cells (Figure 6C). Under the same conditions, full-
length FZD8 antagonized the effects of FZC18, increasing CRT
(Figure 6C), supporting the data shown in Figure 6B. Effects of
full-length FZD8 receptor, FZD8_CRD and FZD8_CRD-GPI on
cells expressing the empty vector are provided on Figure S9.
These results show an additive effect of FZC18 and either
FZD8_CRD or FZD8_CRD-GPI, the dose-response curve
outlining a higher efficacy of FZD8_CRD-GPI. Thus, Wnt/b-
catenin signaling can be concomitantly downregulated by different
Wnt-binding proteins. As FZD8_CRD is soluble, its cell surface
bioavailability may thus be lower than that of FZD8_CRD-GPI,
probably resulting in lower Wnt inhibitory activity.
Taken together, these data underline the specificity of the Wnt
inhibitory activity of FZC18. As FZD receptors rescued Wnt/b-
catenin signaling, but FZD CRDs further enhanced the inhibitory
Figure 5. Partially purified FZC18 inhibits Wnt3a-induced Wnt/
b-catenin signaling. CRT assay using the b-catenin reporters Super8-
NTopflash and Super8NFopflash, as indicated. (A) HEK293-EBNA cells
incubated for 16 hr with either 50% control CM or 50% Wnt3a CM.
Wnt3a induces an 80-fold increase in CRT. (B and C) Partially purified, Fc
tagged human FZC18_CRD (hFZC18_CRD-Fc) dose-dependently inhib-
its Wnt3a-induced CRT in HEK293-EBNA cells, as shown with Super8-
NTopflash (B) and Super8NFopflash (C) CRT reporters. Cells were
incubated for 16 hr with 50% Wnt3a CM that had been pre-incubated
overnight on a rotary wheel at +4uC with the indicated concentrations
of hFc tag alone (recombinant human Fc from IgG, negative control) or
hFZC18_CRD-Fc. Results are shown as mean6SD of hFZC18_CRD-Fc/
hFc tag ratios. R2 indicates 2nd degree polynomial regression coefficient.
Curve fitting is shown by a red line. Super8NFopflash (C) negative
control CRT reporters (C) are shown for the highest concentrations of
hFZC18_CRD-Fc/hFc. (D) Immunoblots show hFc and hFZC18_CRD-Fc
from each sample using anti-Fc tag antibody.
doi:10.1371/journal.pone.0030601.g005
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effects of FZC18, these findings indicate that the effects of FZC18
may not result from endoplasmic reticulum toxicity through
clogging of the secretion pathway with cysteine-rich proteins.
FZC18 forms homodimers and binds the CRDs of FZD1
and FZD8 receptors
One of the well-known features of frizzled CRDs is their
capacity to form homo and heterodimers [4], conferring to SFRPs
the ability to bind to frizzled receptor CRDs [5]. To investigate
whether these features applied to FZC18, we cotransfected
HEK293T cells with both V3Nter-V5 and FZC18-myc or with
V2Nter-V5 and FZC18-myc (Figure 7, A and B). V3Nter is a
precursor of FZC18 originated by endogenous proteolysis in
human tissues [7]. V2Nter-V5 contains the same aminoterminal
sequences of C18 as V3Nter, but lacks the FZC18 domain
(Figure 7A). As both V2Nter and V3Nter share the DUF-959
domain, V2Nter was used as a negative control. Immunoprecip-
itation with anti-myc, followed by immunoblotting with anti-DUF-
959 or with anti-V5 tag antibodies showed that FZC18 bound
V3Nter but not V2Nter. This also excludes the possibility that
FZC18 could bind other portions of the V3Nter molecule, such as
the DUF-959 or the Tsp-1 domains (Figure 7A).
Next, we tested whether FZC18 could bind the CRDs of FZ
receptors. To this end, we used soluble FZD1 or FZD8 CRDs
fused to the Fc portion of human IgG (Figure 7C). Adding
recombinant FZD1_CRD-Fc or FZD8_CRD-Fc CM to non-
concentrated FZC18 CM and immunoprecipitating with protein
G coated beads, followed by immunobloting with anti-myc
antibody showed that FZC18 could bind FZD1 and FZD8 CRDs.
Taken together, the results suggest a model whereby FZC18 could
bind both Wnts and FZD CRDs, hampering access of Wnts to the
FZD receptors, thus blocking Wnt/b-catenin pathway activation
in an SFRP-like mode (Figure 8).
Discussion
The microenvironment impacts Wnt activity and regulates cell
behavior through extracellular molecules that fine tune the
response to Wnt stimuli [5,23]. Proteolysis in human tissues
releases active FZC18 and tumors containing high levels of FZC18
show low b-catenin activation levels [7]. FZC18 behaves as an
SFRP-like molecule inhibiting in vivo cell proliferation and tumor
growth [8]. Although Wnt3a and FZC18 were shown to interact in
a cell overexpression system [7], whether the interaction was still
active in a cell-free system at physiological concentrations
remained unknown. Here, we show that soluble FZC18 binds
Wnt3a and the receptors FZD1 and FZD8, and reduces cell
sensitivity to Wnt3a. FZC18 inhibitory effects are partially rescued
by FZD1 and FZD8 receptors, but enhanced by FZD8_CRD-
GPI, a cell-surface-tethered FZD8_CRD chimera. Altogether, the
results suggest that FZC18 shifts the sensitivity of cells to Wnt
stimuli to a lower pitch, slowing their growth rate.
Although the concentration of soluble FZC18 in the condi-
tioned medium was several fold lower than that of FZD8_CRD, a
well-known partner of Wnt3a [6], Wnt3a was efficiently pulled
down by FZC18. Accordingly, Wnts bind to FZD CRDs with
affinities lower than 90 nM [13,17,18,19,20]. In the present
report, the use of soluble FZC18 at very low concentrations and a
Wnt3a concentration within the physiological range (2.7 nM)
indicates that spurious interactions of highly concentrated
cysteine-rich proteins are unlikely. In addition, we show that
FZC18 binds FZD1 and FZD8 CRDs, implying that FZC18 could
form nonfunctional complexes with the frizzled receptors, thus
acting as a dominant negative inhibitor of Wnt signaling.
Figure 6. Frizzled 1 and 8 receptors partially rescue the
inhibition of Wnt3a-induced CRT by FZC18. CRT reporter gene
assays using the b-catenin-TCF responsive reporter Super8NTopflash in
HEK293T cells stably expressing FZC18 (A, B and C) and vector (A, B).
Twenty-four hours after transfection with the CRT reporter and
increasing amounts of either FZD1 receptor (A), FZD8 receptor (B),
FZD8 receptor, FZD8_CRD or FZC8_CRD-GPI (C) cDNAs, cells were
incubated either with 50% control CM (L) or with 50% Wnt3a CM for
16 hr. Results are representative of three independent experiments
performed in triplicate and normalized to Renilla luciferase activity.
Error bars represent standard deviations.
doi:10.1371/journal.pone.0030601.g006
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The major technical hardship of this work was the low yield of
soluble FZC18. Expression of FZC18 using different vectors and
mammalian host cell systems, allowing either genomic DNA
integration or high copy number episomal replication of target
sequences yielded low amounts of soluble FZC18 (not shown).
Similarly, generation of isogenic stable mammalian cell lines using
Flp recombinase and optimal site-specific genomic recombination
failed to increase the yield of soluble FZC18 (not shown). Since we
demonstrated that the CRD of FZC18 can form homodimers, we
hypothesized that homodimerization could increase yield of
soluble protein and expressed human FZC18_CRD sequences in
frame with the Fc fragment of IgG in CHO cells. This vector/host
combination dramatically increased yield of soluble FZC18_CRD
in the medium. Furthermore, partially purified recombinant
hFZC18_CRD-Fc inhibited Wnt/b-catenin signaling induced by
soluble Wnt3a, confirming that the Wnt inhibitory activity resides
within the frizzled CRD of FZC18.
Overexpression of either FZD1 or FZD8 receptors partially
rescued Wnt signaling in FZC18-expressing cells. On the other
hand, FZD8_CRD-GPI, which remains tethered to the cell
surface, enhanced the inhibitory effect of FZC18 more efficiently
than FZD8_CRD did, which freely diffuses into the medium.
Therefore, competing CRDs may diminish sensitivity to Wnt
ligands at the cell surface. Accordingly, recent evidence indicates
that FZD receptors may be limiting partners in Wnt signal
reception because decreased Wnt/Wg signaling resulting from
ubiquitylation of FZD receptors can be rescued by FZD receptor
overexpression [24].
Finally, Wnt signaling outputs rely not only on ligand and
receptor availability at the cell surface, but also on the
microenvironment that can either enhance (such as heparan
sulfate proteoglycans) [2] or blur (such as SFRPs, DKKs or
FZC18) ligand/receptor interactions. In normal adult human
tissues, FZC18 is released by stepwise proteolytic cleavage from a
cell surface variant of collagen XVIII [9] [7] which is expressed at
low levels. Its expression is up-regulated in liver fibrosis and in
small, well-differentiated tumors, but decreases in advanced
human liver cancers. Indeed, low FZC18 immunostaining in liver
cancers correlates with markers of high Wnt/b-catenin activity
[7]. Since the release of biologically active FZC18 is controlled by
so far unidentified proteases, it is possible that cell growth or tumor
invasion facilitate the local release of FZC18, conveying negative
feedback cues to control cell fate. Therefore, further work is
necessary to determine if FZC18 works as a cell surface sensor of
proteolysis.
Ectopically expressed FZC18 blocks Wnt signaling in an SFRP-
like fashion, inhibiting in vivo cell proliferation and tumor growth
through paracrine signals [8]. However, further work will be
necessary to know whether soluble FZC18 inhibits cell prolifer-
ation and tumor growth in vivo. The present work suggests that
soluble FZC18 decreases cell sensitivity to Wnt signals by binding
Wnt3a and the receptors Frizzled 1 and 8. Thus, the full repertoire
of Wnt ligands and frizzled receptors that interact with FZC18
should be defined, as well as its possible interaction with other
molecules of the extracellular matrix. In particular, FZC18 could
signal through the non-canonical Wnt pathway to decrease cell
Figure 7. The FZC18 domain homodimerizes and binds FZD1 and FZD8 CRDs. (A) Schematic structure of V3Nter, V2Nter and FZC18 cDNAs.
V3Nter and V2Nter correspond to the N-terminal noncollagenous domains of variants 3 and 2 of collagen XVIII, respectively. They share the DUF-959
domain, a portion of the tsp-1 (thrombospondin-1) domain and the V5 tag. Only V3Nter contains the FZC18 domain. The FZC18 vector has a myc tag.
Thick horizontal lines indicate the antibodies used. (B) FZC18 can homodimerize. FZC18-myc was cotransfected with V3Nter-V5 or V2Nter-V5 in
HEK293-EBNA cells. Cell lysates were immunoprecipitated with anti-myc and immunoblotted with anti-DUF-959 (top). The membrane was stripped
and re-probed with anti-V5 (bottom). Ig, immunoglobulins. (C) Soluble FZC18 binds FZD1_CRD and FZD8_CRD. CM from HEK293-EBNA cells secreting
FZC18-myc was incubated with recombinant 100 ng/ml FZD1_CRD-Fc (upper panel) or with CM from HEK293-EBNA cells secreting FZD8_CRD-Fc
(lower panel). FZD1_CRD-Fc and FZD8_CRD-Fc were immunoprecipitated with protein G magnetic beads, electrophoresed and immunoblotted with
anti-myc, anti-FZD1_CRD or anti-FZD8_CRD, as shown. Asterisks denote inputs or FZC18 cell lysate, as indicated.
doi:10.1371/journal.pone.0030601.g007
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proliferation. Comparison of binding affinities of FZC18 with
soluble and, as yet unknown, extracellular-matrix-tethered ligands
will help better understand the physiological role of this collagen-
embedded frizzled CRD.
Supporting Information
Figure S1 Secretion of FZC18 in the cell medium. (A)
Schematic structure showing the FZC18 expression vector. Thick
horizontal lines indicate the antibodies used. SP, signal peptide;
CRD, cysteine-rich domain; myc, myc epitope tag. (B) Phase
contrast images of HEK293T cell batches stably expressing
FZC18 (1; 4 and 5) or empty vector (V). Original magnification
6100. (C) Cells were cultured in suspension with neither FBS nor
phenol red during 3 days. Conditioned media were collected,
dialyzed against deionized water, lyophilized and 150 mg was
analyzed by immunoblot using anti-myc and anti-FZC18
antibodies, as indicated. As a positive control, 10 mg of lysate of
cells stably expressing FZC18 was used (cells). Arrows indicate
FZC18. The asterisk indicates a nonspecific band.
(EPS)
Figure S2 FZC18 inhibits cell proliferation. Proliferation of
HEK293T cells expressing FZC18 was assessed by the MTT
colorimetric assay measuring mitochondrial activity in living cells
on an 8-day time course and is shown as mean6SD of three
replications. Results are representative of three independent
experiments performed in triplicate.
(EPS)
Figure S3 FZC18 reduces basal level and Wnt3a-induced b-
catenin stabilization and cyclin D1 expression. (A) b-catenin assay
stabilization assay using anti-b-catenin, anti-non-phosphorylated
b-catenin and anti-GAPDH (loading standard) antibodies and (B)
cyclin D1 luciferase promoter reporter assay. Cells were incubated
with either 50% control or Wnt3a conditioned medium (CM) for
16 hr before lysis. Reporter assays are representative of three
independent experiments performed in triplicate and normalized
to Renilla luciferase activity (mean6SD). (C) Cells stably
expressing FZC18 (batch #5) or vector were incubated with
50% control (2) or Wnt3a (+) CM for 16 hr. Total protein
extracts from these cells were analyzed by immunoblot detecting
cyclin D1. GAPDH is a loading standard. (D) FZC18 reduces cell
sensitivity to soluble Wnt3a. Relative CRT in vector or FZC18
cells (batch #5) incubated with increasing concentrations of
control or Wnt3a CM for 16 hr (compare relative CRT values in
vector versus FZC18 cells). (E) Aliquots of control (0%) or
increasing concentrations of Wnt3a CM (3–100%) from B were
immunoblotted with anti-Wnt3a.
(EPS)
Figure S4 Wnt3a induces similar fold-change in Wnt signaling
in vector- and FZC18-expressing cells. CRT reporter gene assays
using the b-catenin-TCF reporter Super8NTopflash (A) and the
negative control reporter Super8NFopflash (B) in HEK293T cells
stably expressing vector or FZC18, as indicated. Twenty-four
hours after transfection with the CRT reporters, cells were
incubated with serial dilutions of either control CM (from parental
L cells) or Wnt3a CM (from L cells secreting Wnt3a) for 16 hr.
Results are representative of three independent experiments
performed in triplicate and normalized to Renilla luciferase
activity. For each dilution of control and Wnt3a CM, fold-changes
in CRT were calculated as: (Firefly/Renilla luciferase Wnt3a
CM)/(Firefly/Renilla luciferase control CM).
(EPS)
Figure S5 FZC18 is a cell membrane-associated protein which
binds Wnt3a in its soluble form. (A) Localization of FZC18 in cell
membranes. Immunofluorescent detection of FZC18 N-terminal
(red) and C-terminal (green) epitopes in non permeabilized
HEK293T cell batches stably expressing FZC18 (FZC18 #1;
#4 and #5) or empty vector (vector). Both epitopes colocalize,
outlining cell membranes (arrows). Images were acquired with an
Axio Imager M1 and Colibri LED system and AxioVision
software (Zeiss) at original magnification 6400 (Vector and cell
batches FZC18 #1 and #4) and61000 (batch #5). (B) FZC18 is
exclusively detected in the crude cell membrane fraction. Cytosol
and crude cell membranes from HEK293T cell batches expressing
FZC18 (1; 4; 5) or vector (v) were immunobloted with anti-myc. a-
tubulin and caveolin-2 are loading standards of cytosol and crude
membrane fractions, respectively. (C) Lower yields of soluble
FZC18-myc than of FZ8_CRD-myc in transiently transfected
HEK293-EBNA cell CM. Both proteins were detected by
immunoblot with mouse anti-myc antibody followed by goat
anti-mouse peroxidase conjugate. Signal was revealed by en-
hanced chemiluminescence. Arrows indicate FZC18-myc
(,31 kD) and FZ8_CRD-myc (,45 kD). Brackets show serum
immunoglobulins. The FZC18 blot shows: 1x, whole CM from
cells expressing (+) or not (2) FZC18; 13x, trichloroacetic acid
(TCA) concentrated whole CM from cells expressing (+) or not (2)
Figure 8. Hypothetical model for the mode of action of FZC18.
High: in the absence of FZC18, Wnt3a increases b-catenin signaling.
Low: FZC18 binds Wnt3a and FZD receptors, blocking Wnt/b-catenin
pathway activation in an SFRP-like mode of action. Rescued: FZC18
inhibitory effects can be partially rescued by increasing the number of
FZD receptors at the cell surface.
doi:10.1371/journal.pone.0030601.g008
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FZC18; 60x, Amicon centrifugal concentration of whole CM from
cells expressing (+) or not (2) FZC18. The FZ8_CRD blot shows:
13x (2), TCA concentrated whole CM from untransfected
HEK293-EBNA cells; 1x (+)(+) whole CM from HEK293-EBNA
cells transiently expressing FZ8_CRD from batches #1 and #2;
13x (+)(+) TCA-concentrated CM from HEK293-EBNA cells
transiently expressing FZ8_CRD from batches #1 and #2; 60x
(+)(+) Amicon centrifugal concentration of whole CM from
HEK293-EBNA cells transiently expressing FZ8_CRD from
batches #1 and #2. (D) Soluble Wnt3a pulls down FZC18 from
the HEK293-EBNA CM. Conditioned medium containing soluble
FZC18-myc was incubated with recombinant Wnt3a overnight at
+4uC. Wnt3a was immunoprecipitated with monoclonal rabbit
anti-Wnt3a and immunoblotted with anti-myc. CM from
HEK293-EBNA cells transiently expressing FZ8_CRD-myc was
used as a positive control of coimmunoprecipitation. Ig, immuno-
globulins. (E) CM from HEK293-EBNA cells transiently express-
ing FZC18 was incubated with recombinant Wnt3a overnight at
+4uC. FZC18 was immunoprecipitated with anti-myc. In this
figure, the blot from Figure 4D was stripped and immunoblotted
with anti-myc. CM from HEK293-EBNA cells transiently
expressing FZ8_CRD-myc was used as a positive control of
coimmunoprecipitation. Ig, immunoglobulins.
(TIF)
Figure S6 Partially purified (40% purity) hFZC18_CRD-Fc
proteins containing (#1) or not (#2) a thrombin cleavage site are
equally efficient in inhibiting Wnt3a-induced CRT. (A) Schematic
representation of hFZC18_CRD-Fc constructs containing (#1) or
not (#2) a thrombin cleavage site. Empty Fc expression vector is
also shown. (B) Coomassie blue staining. Two mg of protein was
run in a reducing 7% PAGE-SDS gel. Theoretical molecular
weights of #1 and #2 are 42407 Da and 41792 Da, respectively
(8 additional aminoacids from the thrombin cleavage site in #1).
Migration of #1 appears lightly faster than that of #2 because pI
of #1 (6.35).pI of #2 (6.23). (C) Partially purified,
hFZC18_CRD-Fc proteins containing (#1) or not (#2) a
thrombin cleavage site are equally efficient in inhibiting Wnt3a-
induced CRT. Both proteins dose-dependently inhibit Wnt3a-
induced CRT in HEK293-EBNA cells. CRT assay using the b-
catenin reporter Super8NTopflash. Twenty-four hours after
transfection with the CRT reporter, cells were incubated during
16 hr with either 50% control CM or 50% Wnt3a CM that had
been pre-incubated overnight on a rotary wheel at +4uC with the
indicated concentrations of hFc tag alone (recombinant human Fc
from IgG, negative control) or hFZC18_CRD-Fc proteins.
(EPS)
Figure S7 Paracrine inhibition of Wnt3a-induced Wnt/b-
catenin signaling by FZC18. (A) Schematic representation of the
coculture experiment. (B) Relative CRT in reporter 293T cells
transfected with the Super8NTopflash reporter and co-cultured
with 293T cells stably expressing FZC18 or empty vector at
different ratios, as indicated, in the presence of 25% Wnt3a CM
for 16 hr. (C) Total protein extracts from these cells were
immunoblotted with anti-myc detecting FZC18. The same blot
was probed with anti-GAPDH as a loading standard.
(EPS)
Figure S8 Negative control CRT reporter gene assays using the
mutated b-catenin-TCF reporter Super8NFopflash in HEK293T
cells stably expressing FZC18 (A, B and C) or vector (A, B).
Twenty-four hours after transfection with the CRT reporter and
increasing amounts of either FZD1 receptor (A), FZD8 receptor
(B), FZD8 receptor, FZD8_CRD or FZC8_CRD-GPI (C) cDNAs,
cells were incubated either with 50% control CM or with 50%
Wnt3a CM for 16 hr. Results are representative of three
independent experiments performed in triplicate and normalized
to Renilla luciferase activity. Error bars represent standard
deviations.
(EPS)
Figure S9 Wnt3a-induced CRT in HEK293T cells is enhanced
by FZD8 receptor and inhibited by FZD8_CRD or FZD8_CRD-
GPI cDNA. CRT reporter gene assays using the b-catenin-TCF
responsive reporter Super8NTopflash in HEK293T cells stably
expressing empty vector. Twenty-four hours after transfection with
the CRT reporter and increasing amounts of FZD8 receptor,
FZD8_CRD or FZC8_CRD-GPI cDNAs, cells were incubated
with either 50% control CM or 50%Wnt3a CM for 16 hr. Results
are representative of three independent experiments performed in
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